Key result
Catheter ablation improves AF arrhythmia outcomes versus AADs without increasing serious adverse events.
Why the study?
The field of catheter ablation for AF has undergone significant advancements in recent years, warranting an overview of current techniques, emerging technologies, and future directions.
What are the current techniques, emerging technologies, and future directions for catheter ablation of atrial fibrillation?
What are the current techniques, emerging technologies, and future directions for catheter ablation of atrial fibrillation?
Catheter ablation is a well-established treatment for atrial fibrillation that improves arrhythmia outcomes without increasing serious adverse events compared to antiarrhythmic drugs, with pulmonary vein isolation remaining the cornerstone technique.
Answers are grounded in this paper and cite their sources.
Supports ablation over drugs for AF rhythm control; leaves open optimal use of emerging technologies.
Atrial fibrillation is the most common sustained cardiac arrhythmia with a significant impact on quality of life in terms of symptoms and reduction of functional status. Also, it is associated with an increased risk of mortality, stroke, and peripheral embolism. Catheter ablation for atrial fibrillation has become a well-established treatment, improving arrhythmia outcomes without increasing the risk of serious adverse events compared to antiarrhythmic drug therapy. The field has undergone significant advancements in recent years, yet pulmonary vein isolation continues to be the cornerstone of any atrial fibrillation ablation procedure. The purpose of this review is to provide an overview of the current techniques, emerging technologies, and future directions.
No takes yet. Share an insight, caveat, or question.
Peruzza et al. (2025) conducted a review in Atrial fibrillation. Catheter ablation vs. Antiarrhythmic drug therapy was evaluated. Catheter ablation for atrial fibrillation improves arrhythmia outcomes without increasing the risk of serious adverse events compared to antiarrhythmic drug therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: